Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 9

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 9
---
 2024 Say-on-Pay Vote   | ​ |
| ​ | 77 | ​ | ​ | Compensation Tables    | ​ |
| ​ | 87 | ​ | ​ | Pay Versus Performance | ​ |

TABLE OF CONTENTS Forward-Looking Statements This proxy statement includes estimates, projections, statements relating to our business plans, strategies, objectives and expected operating results that are “forward- looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may appear throughout this proxy statement. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “can,” “could,” “estimate,” “expect,” “future,” “intend,” “may,” “opportunity,” “plan,” “project,” “should,” “strategy,” “will,” “will be,” “will continue,” “will likely result,” “would,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that may cause actual results to differ materially. We describe risks and uncertainties that could cause actual results and events to differ materially in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2024. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law.

TABLE OF CONTENTS

| ​ | ​ | 2025PROXYSTATEMENTSUMMARY | ​ |

| ​ |                             | ​ | ​ | ​                                   | ​ | ​ | ​            | ​ | ​ | ​                 | ​ | ​ | ​                     | ​ | ​ | ​                         | ​ | ​ | ​                                           | ​ | ​ | ​                     | ​ | ​ | ​          | ​ | ​ | ​          | ​ |
| ​ | 2025PROXY STATEMENT SUMMARY | ​ | ​ | CORPORATEGOVERNANCEAND BOARDMATTERS | ​ | ​ | AUDITMATTERS | ​ | ​ | EXECUTIVEOFFICERS | ​ | ​ | EXECUTIVECOMPENSATION | ​ | ​ | STOCKOWNERSHIPINFORMATION |